Varian Medical Systems SVP Sells $94,772 in Stock (VAR)
Varian Medical Systems (NYSE:VAR) SVP Kolleen Kennedy sold 1,247 shares of Varian Medical Systems stock on the open market in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $76.00, for a total transaction of $94,772.00. Following the transaction, the senior vice president now directly owns 6,236 shares of the company’s stock, valued at approximately $473,936. The transaction was disclosed in a document filed with the SEC, which is available at this link.
A number of analysts have recently weighed in on VAR shares. Analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems (NYSE:VAR) in a research note to investors on Monday, September 16th. They now have a $78.00 price target on the stock. Finally, analysts at Brean Capital raised their price target on shares of Varian Medical Systems (NYSE:VAR) from $76.00 to $80.00 in a research note to investors on Thursday, July 25th. They now have a “buy” rating on the stock.
Two analysts have rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $75.00.
Varian Medical Systems (NYSE:VAR) traded up 0.22% on Monday, hitting $76.27. 637,270 shares of the company’s stock traded hands. Varian Medical Systems has a 1-year low of $57.00 and a 1-year high of $76.69. The stock has a 50-day moving average of $73.14 and a 200-day moving average of $70.37. The company has a market cap of $8.211 billion and a P/E ratio of 19.15.
Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, July 24th. The company reported $1.03 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.01 by $0.02. The company had revenue of $726.20 million for the quarter, compared to the consensus estimate of $749.01 million. During the same quarter in the prior year, the company posted $0.96 earnings per share. The company’s quarterly revenue was up 3.0% on a year-over-year basis. Analysts expect that Varian Medical Systems will post $4.03 EPS for the current fiscal year.
Varian Medical Systems, Inc is engaged in the design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy (NYSE:VAR), stereotactic radiosurgery (SRS) and brachytherapy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.